Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hut 8 Corp (HUT) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance

Hut 8 CorpTrade
IDEXX Laboratories, Inc.Trade

Price performance (Past 24H)

Key statistics

Hut 8 Corp vs IDEXX Laboratories, Inc. — how do they compare? Hut 8 Corp trades at $105.06 (market cap $11.36B), while IDEXX Laboratories, Inc. trades at $560 (market cap $44.48B). The key difference: IDEXX Laboratories, Inc. is far larger — about 3.9× Hut 8 Corp's market cap, and Hut 8 Corp is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.

HUTIDXX
Market Cap
$11.36B$44.48B
Sector
TechnologyHealth
52-Week High
$133.02$766.68
52-Week Low
$19.45$520.87
Enterprise Value
$11.63B$45.38B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hut 8 Corp

HUT trades at $100.93, up 10.37% in the past 24 hours, with a bearish technical signal from moving averages and oscillators. The company reported a net loss of $226.15 million in 2025 despite revenue of $235.12 million, though it beat EPS estimates in two of the last three quarters. Recent news highlights its pivot to AI infrastructure, including a $4.25 billion bond issuance for data center projects (PRNewsWire, 2026-06-09).

Analyst consensus is strongly bullish with a $138.89 price target, but high valuation ratios and persistent losses pose risks. The stock's outlook hinges on successful execution of its digital infrastructure strategy, though cash flow challenges and competitive pressures remain key concerns for investors.

IDEXX Laboratories, Inc.

IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.

Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Hut 8 Corp

Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.

Read more on HUT

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Read more on IDXX